Scientists at the School of Public Health and Medicine will lead a research study that could result in more effective treatments for serious lung and central nervous system infections.
The study will cost $21.4 million and is headed by Ralph Baric, an epidemiology professor, and Mark Heise, an associate professor of genetics.
The goal of the project is to identify central regulatory genes and networks that control disease severity, communicate between immune departments and determine disease outcomes.
UNC will collaborate with a team of researchers from the University of Washington, the Fred Hutchinson Cancer Center in Seattle and the Oregon Health Sciences Center.
